Drug intelligence / Profile preview

Liangge San

Development stage
Preclinical
Lead developer
Tianjin First Central Hospital
Administration
Oral
01

Overview

Liangge San (also known as Liang-Ge-San or Liangge decoction) is a classic traditional Chinese medicine (TCM) formula composed of several herbal ingredients, including *Forsythia suspensa*, *Rheum palmatum*, *Scutellaria baicalensis*, *Gardenia jasminoides*, *Glycyrrhiza uralensis*, *Mentha canadensis* (or *Mentha haplocalyx*), *Lophatherum gracile*, and sodium sulfate. It is traditionally used to clear heat, purge fire, and relieve toxicity. In modern clinical research, Liangge San is being evaluated for the treatment of sepsis, sepsis-associated intestinal dysfunction, and acute lung injury. Its therapeutic effects are believed to be mediated through anti-inflammatory pathways, including the inhibition of glycogen synthase kinase-3 beta (GSK-3β) expression, suppression of the NF-κB pathway, and activation of the cholinergic anti-inflammatory pathway, which collectively reduce inflammatory cell infiltration and cytokine release.

Other names
Liang Ge SanLiang-Ge-SanLiangge decoctionLiangge granulesLiangge powder凉膈散
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)CHRNA7 (α7 nicotinic receptor)GSK3 (Glycogen synthase kinase 3 beta)

Beyond the preview

Go deeper on Liangge San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liangge San.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call